M&A Deal Summary

EmeritusDX Acquires SprintDx

On July 2, 2024, EmeritusDX acquired medical products company SprintDx

Acquisition Highlights
  • This is EmeritusDX’s 1st transaction in the Medical Products sector.
  • This is EmeritusDX’s 2nd transaction in the United States.
  • This is EmeritusDX’s 1st transaction in California.

M&A Deal Summary

Date 2024-07-02
Target SprintDx
Sector Medical Products
Buyer(s) EmeritusDX
Deal Type Add-on Acquisition

Target

SprintDx

Santa Ana, California, United States
SprintDx is a dynamic laboratory known for its cutting-edge diagnostic services and customer-first approach, serving healthcare providers with reliable and efficient testing solutions. Sprint Diagnostics is based in Santa Ana, California.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

EmeritusDX

Irvine, California, United States

Category Company
Sector Healthcare Services
DESCRIPTION

EmeritusDX is a cancer diagnostic and information company. EmeritusDX expertise is in delivering actionable clinical information. Within EmeritusDX laboratory performs testing that guides the diagnosis and treatment of cancer patients. EmeritusDX is based in Irvine, California.


DEAL STATS #
Overall 2 of 2
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 2 of 2
State (California) 1 of 1
Country (United States) 2 of 2
Year (2024) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-06-13 Freedom Pathology Partners

Conshohocken, Pennsylvania, United States

Freedom Pathology Partners is a national, privately owned, anatomic pathology laboratory that offers sub-specialization in gastrointestinal pathology, providing access to pathologists specially trained in GI pathology who provide superior pathology services to gastroenterologists and their patients. Freedom Pathology Partners is based in Conshohocken, Pennsylvania.

Buy -